Amgen paid its 5 named executives $58.8M in total in FY2025 (Dec). CEO Robert A. Bradway was paid $24.7M of that.
Pay$100 in the stock at the end of FY09 → $238
Pay of each named executive
Robert A. BradwayChief Executive Officer and President
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) | ||||||
| FY2012 (Dec) | ||||||
| FY2011 (Dec) | ||||||
| FY2010 (Dec) |
8 years
James E. BradnerExecutive Vice President, Research and Development
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Peter H. GriffithExecutive Vice President and Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Murdo GordonExecutive Vice President, Global Commercial Operations
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
David M. ReeseExecutive Vice President and Chief Technology Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
CEO pay against the pay peers
In FY2024 (Dec), the median CEO pay of the 9 peers with pay on file was $23.7M. The CEO of Amgen was paid $24.4M, 3% above the median.
- 1Eli Lilly & Co
- 2Pfizer
- 3AmgenThis company
- 4Johnson & Johnson
- 5Biogen
- 6Gilead Sciences
- 7Merck & Co.
- 8Bristol Myers Squibb
- 9AbbVie
- 10Regeneron Pharmaceuticals
- 11AstraZeneca plcNot disclosed
- 12GlaxoSmithKline plcNot disclosed
- 13Novartis AGNot disclosed
- 14Roche Holding AGNot disclosed
- 15Sanofi S.A.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.